Literature DB >> 1852385

Orbital exenteration with eyelid sparing: indications, technique, and results.

J A Shields1, C L Shields, C Suvarnamani, M Tantisira, P Shah.   

Abstract

Of 22 orbital exenterations performed from January 1980 to December 1989, 16 were performed by an eyelid-sparing technique, and six were allowed to heal by spontaneous granulation. Reviewing these procedures, we conclude that the eyelid-sparing method is indicated mainly for advanced primary orbital malignancies and for certain secondary orbital malignancies such as orbital extension of uveal melanoma, conjunctival melanoma, and conjunctival squamous cell carcinoma. It is not usually applicable to orbital invasion of malignant eyelid tumors such as basal cell carcinoma and sebaceous gland carcinoma. Advantages of the eyelid-sparing method are more rapid healing and earlier fitting of a prosthesis.

Entities:  

Mesh:

Year:  1991        PMID: 1852385

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  13 in total

1.  Orbital exenteration: surgical and reconstructive strategies.

Authors:  C Mohr; J Esser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

2.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

3.  Orbital exenteration: a 13 year Manchester experience.

Authors:  I Rahman; A E Cook; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2000

5.  Reconstruction of orbital exenteration defects with bilobed forehead flap.

Authors:  Ayşe Dolar Bilge; Bulent Yazici; Fikret Kasapoglu
Journal:  Int Ophthalmol       Date:  2016-03-09       Impact factor: 2.031

Review 6.  [Tumors and tumor-like lesions of the orbit].

Authors:  W E Lieb
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

7.  Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India.

Authors:  Mohammad Javed Ali; Aditi Pujari; Tarjani Vivek Dave; Swathi Kaliki; Milind N Naik
Journal:  Int Ophthalmol       Date:  2015-08-07       Impact factor: 2.031

8.  Exenteration for benign orbital disease.

Authors:  G E Rose; J E Wright
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

9.  Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.

Authors:  Swathi Kaliki; Swati Singh; Sadiya Iram; Dharani Tripuraneni
Journal:  Indian J Ophthalmol       Date:  2016-10       Impact factor: 1.848

Review 10.  Ocular surface squamous neoplasia in HIV-infected patients: current perspectives.

Authors:  Shweta Gupta Rathi; Anasua Ganguly Kapoor; Swathi Kaliki
Journal:  HIV AIDS (Auckl)       Date:  2018-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.